Acadian Asset Management
GSK icon

Acadian Asset Management’s GSK GSK Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$108M Sell
2,824,745
-1,157,579
-29% -$44.4M 0.22% 100
2025
Q1
$154M Buy
3,982,324
+2,663,270
+202% +$103M 0.44% 56
2024
Q4
$44.6M Sell
1,319,054
-2,747,133
-68% -$92.9M 0.13% 162
2024
Q3
$166M Buy
4,066,187
+2,355,935
+138% +$96.3M 0.52% 41
2024
Q2
$65.8M Sell
1,710,252
-509,546
-23% -$19.6M 0.2% 119
2024
Q1
$95.1M Buy
2,219,798
+1,426,935
+180% +$61.2M 0.33% 86
2023
Q4
$29.4M Sell
792,863
-551,668
-41% -$20.4M 0.11% 162
2023
Q3
$48.7M Sell
1,344,531
-2,862,669
-68% -$104M 0.2% 128
2023
Q2
$150M Sell
4,207,200
-736,087
-15% -$26.2M 0.62% 34
2023
Q1
$176M Sell
4,943,287
-1,612,345
-25% -$57.4M 0.77% 17
2022
Q4
$230M Buy
6,555,632
+43,870
+0.7% +$1.54M 1.13% 7
2022
Q3
$192M Sell
6,511,762
-4,218,492
-39% -$124M 1.05% 12
2022
Q2
$467M Buy
10,730,254
+7,330,241
+216% +$319M 2.39% 3
2022
Q1
$148M Buy
3,400,013
+1,611,899
+90% +$70.2M 0.61% 39
2021
Q4
$78.8M Buy
1,788,114
+1,480,492
+481% +$65.3M 0.29% 96
2021
Q3
$11.7M Buy
307,622
+105,028
+52% +$4.01M 0.04% 280
2021
Q2
$8.07M Sell
202,594
-1,420,993
-88% -$56.6M 0.03% 360
2021
Q1
$57.9M Buy
+1,623,587
New +$57.9M 0.23% 110
2018
Q2
Sell
-7,884
Closed -$310K 1760
2018
Q1
$310K Sell
7,884
-36,784
-82% -$1.45M ﹤0.01% 964
2017
Q4
$1.59M Buy
44,668
+28,192
+171% +$1M 0.01% 599
2017
Q3
$669K Buy
+16,476
New +$669K ﹤0.01% 744
2017
Q1
Sell
-666
Closed -$26K 1642
2016
Q4
$26K Hold
666
﹤0.01% 1275
2016
Q3
$29K Sell
666
-752
-53% -$32.7K ﹤0.01% 1129
2016
Q2
$61K Buy
+1,418
New +$61K ﹤0.01% 1084
2014
Q4
Sell
-2,315
Closed -$106K 1289
2014
Q3
$106K Buy
2,315
+97
+4% +$4.44K ﹤0.01% 826
2014
Q2
$119K Buy
+2,218
New +$119K ﹤0.01% 845